KEY FEATURES
| Full Name | Granzyme B |
|---|---|
| Synonym | GZM-B;HLP;CTLA1;CCPI;CGL1;CSP-B;CSPB;CTSGL1;SECT;Granzyme 2;Cathepsin G-like 1;T-cell serine protease 1-3E; |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.16-10ng/mL |
| Sensitivity | 0.06ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human GzmB in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human GzmB. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human GzmB and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human GzmB, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human GzmB. You can calculate the concentration of Human GzmB in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human GzmB ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.47 | 1.28 | 3.55 | 0.51 | 1.26 | 3.41 |
| Standard deviation | 0.03 | 0.07 | 0.14 | 0.03 | 0.06 | 0.11 |
| CV(%) | 6.83 | 5.78 | 3.96 | 5.81 | 4.56 | 3.14 |
RECOVERY
The recovery of Human GzmB spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 88-99 | 94 |
| EDTA plasma (n=8) | 88-100 | 93 |
| Cell culture media (n=8) | 96-109 | 102 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human GzmB in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with GZMB ELISA Kits
| PRF1 ELISA Kit | publications with GZMB and PRF1 |
| CASP3 ELISA Kit | publications with GZMB and CASP3 |
| BID ELISA Kit | publications with GZMB and BID |
| SERPINB9 ELISA Kit | publications with GZMB and SERPINB9 |
| CASP7 ELISA Kit | publications with GZMB and CASP7 |
| IL2RA ELISA Kit | publications with GZMB and IL2RA |
| IL2RB ELISA Kit | publications with GZMB and IL2RB |
| IL2 ELISA Kit | publications with GZMB and IL2 |
Pathways associated with GZMB ELISA Kit
| Activation, Myristolyation Of BID And Translocation To Mitochondria Pathway | Activation, Myristolyation Of BID And Translocation To Mitochondria Pathway |
| Allograft Rejection Pathway | Allograft Rejection Pathway |
| Apoptosis Pathway | Apoptosis Pathway |
| Autoimmune Thyroid Disease Pathway | Autoimmune Thyroid Disease Pathway |
| Caspase Cascade In Apoptosis Pathway | Caspase Cascade In Apoptosis Pathway |
| Downstream Signaling In Naive CD8+ T Cells Pathway | Downstream Signaling In Naive CD8+ T Cells Pathway |
| Graft-versus-host Disease Pathway | Graft-versus-host Disease Pathway |
Diseases associated with GZMB ELISA Kit
| Neoplasms | publications with GZMB and Neoplasms |
| Necrosis | publications with GZMB and Necrosis |
| Inflammation | publications with GZMB and Inflammation |
| Neoplasms, Experimental | publications with GZMB and Neoplasms, Experimental |
| Disease Models, Animal | publications with GZMB and Disease Models, Animal |
| Nervous System Diseases | publications with GZMB and Nervous System Diseases |
| Liver Diseases | publications with GZMB and Liver Diseases |
| Hypersensitivity | publications with GZMB and Hypersensitivity |
| Breast Neoplasms | publications with GZMB and Breast Neoplasms |
| Hepatitis | publications with GZMB and Hepatitis |
Organs/Tissues associated with GZMB ELISA Kit
| Blood | publications with GZMB and Blood |
| Kidney | publications with GZMB and Kidney |
| Lung | publications with GZMB and Lung |
| Liver | publications with GZMB and Liver |
| Spleen | publications with GZMB and Spleen |
| Bone Marrow | publications with GZMB and Bone Marrow |
| Heart | publications with GZMB and Heart |
| Intestine | publications with GZMB and Intestine |
| Pancreas | publications with GZMB and Pancreas |
| Stomach | publications with GZMB and Stomach |